Randomised phase II trial of pegylated liposomal doxorubicin (DOXILR/CAELYXR) versus doxorubicin in the treatment of advanced or metastatic sift tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group
Authors
Judson, Ian RRadford, John A
Harris, Maggie A
Blay, Jean-Yves
Van Hoesel, Q
Le Cesne, A
Van Oosterom, A
Clemons, Mark
Kamby, C
Hermans, C
Whittaker, J
Donato di Paola, E
Verweij, Jaap
Nielsen, S
Affiliation
Royal Marsden Hospital, London, UKIssue Date
2001-05
Metadata
Show full item recordCitation
Randomised phase II trial of pegylated liposomal doxorubicin (DOXILR/CAELYXR) versus doxorubicin in the treatment of advanced or metastatic sift tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. 2001, 37(7) : 870-877 Eur J CancerJournal
European Journal of CancerDOI
10.1016/S0959-8049(01)00050-8Type
ArticleLanguage
enISSN
09598049ae974a485f413a2113503eed53cd6c53
10.1016/S0959-8049(01)00050-8